Department of Biomedical Engineering, Nigeria.
Department of Biomedical Engineering, Nigeria; ACE-FUELS-FUTO, Nigeria; David Umahi Federal University of Health Sciences, Uburu, Nigeria.
J Ethnopharmacol. 2025 Jan 30;337(Pt 1):118790. doi: 10.1016/j.jep.2024.118790. Epub 2024 Sep 10.
Blighia sapida, commonly known as Ackee, is a plant native to West Africa, with great cultural and therapeutic value, particularly in Western Nigeria. Traditionally, Blighia sapida capsule is used in western Nigeria to treat ecthyma in sheep and goats by heating it in hot ash. This process causes the capsule to release a liquid, which is then directly applied to the entire affected area of the skin. However, there is limited information available on its phyto-constituents and medicinal effects.
This work examined the bioactive constituents, acute toxicity, and sub-acute toxicity of aqueous and ethanolic extracts of Blighia sapida capsule.
Extraction of phytochemical constituents was carried out with distilled water and ethanol and was concentrated at 40 °C. The phytochemical constituents were determined using a variant 3800/4000 gas chromatography-mass spectrometry (GC-MS) machine. Lorke's method was employed to determine the acute toxicity of the aqueous and ethanolic extracts of Blighia sapida capsule.
The GC-MS analysis revealed 15 bioactive compounds in both extracts, with kaempferol being the most abundant. Notable pharmacologically active compounds included pyrrolidin-2-ylmethanol, rutin, quinoline, apigenin, and naringenin. The study observed distinctive differences in aqueous and ethanolic extracts compound weights and peak areas. Acute toxicity study depicts that the lethal dose of aqueous and ethanolic extracts of Blighia sapida capsule is above 5000 mg/kg as no mortality was recorded in the oral administration of 10, 100, 1000, 1600, 2900, and 5000 mg/kg of aqueous and ethanolic extracts. Sub-acute toxicity results indicated no significant adverse effects on kidney and liver function, although some variations in biochemical parameters were observed. Histological analysis showed normal renal and hepatic architecture in treated animals.
This study demonstrated that aqueous and ethanolic extracts of Blighia sapida capsule exhibited no acute toxicity and minimal sub-acute toxicity, suggesting they are safe for consumption at the tested doses.
Blighia sapida,俗称 ackee,是一种原产于西非的植物,具有重要的文化和治疗价值,特别是在尼日利亚西部。传统上,尼日利亚西部用 Blighia sapida 胶囊来治疗绵羊和山羊的疹,方法是将胶囊在热灰中加热。这一过程会导致胶囊释放出一种液体,然后直接涂抹在皮肤的整个受影响区域。然而,关于其植物成分和药用效果的信息有限。
本研究检测了 Blighia sapida 胶囊的水提物和醇提物的生物活性成分、急性毒性和亚急性毒性。
采用蒸馏水和乙醇提取植物化学成分,并在 40°C 下浓缩。使用变体 3800/4000 气相色谱-质谱联用仪(GC-MS)测定植物化学成分。采用 Lorke 法测定 Blighia sapida 胶囊的水提物和醇提物的急性毒性。
GC-MS 分析显示,两种提取物中均含有 15 种生物活性化合物,其中槲皮素含量最高。值得注意的是,药理学上有活性的化合物包括吡咯烷-2-基甲醇、芦丁、喹啉、芹菜素和柚皮苷。研究观察到水提物和醇提物中化合物重量和峰面积的明显差异。急性毒性研究表明,Blighia sapida 胶囊的水提物和醇提物的致死剂量均超过 5000mg/kg,因为在口服 10、100、1000、1600、2900 和 5000mg/kg 的水提物和醇提物时,没有记录到死亡。亚急性毒性结果表明,肾脏和肝脏功能没有显著的不良反应,尽管一些生化参数有变化。组织学分析显示,在治疗动物中肾脏和肝脏的结构正常。
本研究表明,Blighia sapida 胶囊的水提物和醇提物无急性毒性,亚急性毒性较小,提示在测试剂量下安全可食用。